Enanta Pharmaceuticals Stock Forward View - Simple Moving Average
| ENTA Stock | USD 12.90 0.25 1.98% |
Enanta Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Enanta Pharmaceuticals stock prices and determine the direction of Enanta Pharmaceuticals's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Enanta Pharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns.
At this time, the RSI of Enanta Pharmaceuticals' share price is approaching 48 suggesting that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Enanta Pharmaceuticals, making its price go up or down. Momentum 48
Impartial
Oversold | Overbought |
Quarterly Earnings Growth (0.66) | EPS Estimate Next Quarter (1.02) | EPS Estimate Current Year (3.09) | EPS Estimate Next Year (2.73) | Wall Street Target Price 19.125 |
Using Enanta Pharmaceuticals hype-based prediction, you can estimate the value of Enanta Pharmaceuticals from the perspective of Enanta Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Enanta Pharmaceuticals using Enanta Pharmaceuticals' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Enanta using crowd psychology based on the activity and movement of Enanta Pharmaceuticals' stock price.
Enanta Pharmaceuticals Implied Volatility | 1.08 |
Enanta Pharmaceuticals' implied volatility exposes the market's sentiment of Enanta Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Enanta Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Enanta Pharmaceuticals stock will not fluctuate a lot when Enanta Pharmaceuticals' options are near their expiration.
The Simple Moving Average forecasted value of Enanta Pharmaceuticals on the next trading day is expected to be 12.90 with a mean absolute deviation of 0.40 and the sum of the absolute errors of 23.52. Enanta Pharmaceuticals after-hype prediction price | USD 12.9 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Enanta Pharmaceuticals to cross-verify your projections. Prediction based on Rule 16 of the current Enanta contract
Based on the Rule 16, the options market is currently suggesting that Enanta Pharmaceuticals will have an average daily up or down price movement of about 0.0675% per day over the life of the 2026-04-17 option contract. With Enanta Pharmaceuticals trading at USD 12.9, that is roughly USD 0.008708 . If you think that the market is fully incorporating Enanta Pharmaceuticals' daily price movement you should consider acquiring Enanta Pharmaceuticals options at the current volatility level of 1.08%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-04-17 Enanta Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Enanta Pharmaceuticals' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Enanta Pharmaceuticals' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Enanta Pharmaceuticals stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Enanta Pharmaceuticals' open interest, investors have to compare it to Enanta Pharmaceuticals' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Enanta Pharmaceuticals is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Enanta. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Enanta Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Enanta price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Enanta using various technical indicators. When you analyze Enanta charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Enanta Pharmaceuticals Simple Moving Average Price Forecast For the 31st of January
Given 90 days horizon, the Simple Moving Average forecasted value of Enanta Pharmaceuticals on the next trading day is expected to be 12.90 with a mean absolute deviation of 0.40, mean absolute percentage error of 0.28, and the sum of the absolute errors of 23.52.Please note that although there have been many attempts to predict Enanta Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Enanta Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Enanta Pharmaceuticals Stock Forecast Pattern
| Backtest Enanta Pharmaceuticals | Enanta Pharmaceuticals Price Prediction | Buy or Sell Advice |
Enanta Pharmaceuticals Forecasted Value
In the context of forecasting Enanta Pharmaceuticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Enanta Pharmaceuticals' downside and upside margins for the forecasting period are 9.68 and 16.12, respectively. We have considered Enanta Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of Enanta Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Enanta Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 113.1654 |
| Bias | Arithmetic mean of the errors | -0.0531 |
| MAD | Mean absolute deviation | 0.3986 |
| MAPE | Mean absolute percentage error | 0.0289 |
| SAE | Sum of the absolute errors | 23.52 |
Predictive Modules for Enanta Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Enanta Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Enanta Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Enanta Pharmaceuticals After-Hype Price Density Analysis
As far as predicting the price of Enanta Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Enanta Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Enanta Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Enanta Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Enanta Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Enanta Pharmaceuticals' historical news coverage. Enanta Pharmaceuticals' after-hype downside and upside margins for the prediction period are 9.70 and 16.10, respectively. We have considered Enanta Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Enanta Pharmaceuticals is not too volatile at this time. Analysis and calculation of next after-hype price of Enanta Pharmaceuticals is based on 3 months time horizon.
Enanta Pharmaceuticals Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Enanta Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Enanta Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Enanta Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.34 | 3.22 | 0.07 | 0.12 | 5 Events / Month | 7 Events / Month | In about 5 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
12.90 | 12.90 | 0.00 |
|
Enanta Pharmaceuticals Hype Timeline
Enanta Pharmaceuticals is currently traded for 12.90. The entity has historical hype elasticity of 0.07, and average elasticity to hype of competition of 0.12. Enanta is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is currently at 0.34%. %. The volatility of related hype on Enanta Pharmaceuticals is about 941.52%, with the expected price after the next announcement by competition of 13.02. About 70.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings (P/E) ratio of 366.13. Enanta Pharmaceuticals recorded a loss per share of 3.84. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next anticipated press release will be in about 5 days. Check out Historical Fundamental Analysis of Enanta Pharmaceuticals to cross-verify your projections.Enanta Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Enanta Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Enanta Pharmaceuticals' future price movements. Getting to know how Enanta Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Enanta Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| PYXS | Pyxis Oncology | (0.02) | 7 per month | 0.00 | (0.07) | 17.05 | (15.41) | 70.66 | |
| PRLD | Prelude Therapeutics | 3.80 | 33 per month | 11.51 | 0.08 | 16.44 | (16.17) | 206.09 | |
| TNYA | Tenaya Therapeutics | (0.20) | 5 per month | 0.00 | (0.12) | 10.57 | (11.04) | 51.79 | |
| FHTX | Foghorn Therapeutics | (0.27) | 10 per month | 4.21 | 0.11 | 9.16 | (5.56) | 31.12 | |
| NAUT | Nautilus Biotechnology | (0.01) | 9 per month | 5.41 | 0.1 | 10.66 | (12.00) | 53.15 | |
| CRBU | Caribou Biosciences | (0.13) | 7 per month | 0.00 | (0.19) | 6.86 | (6.41) | 20.16 | |
| IMRX | Immuneering Corp | (1.14) | 8 per month | 0.00 | (0.01) | 8.12 | (5.64) | 67.18 | |
| VYGR | Voyager Therapeutics | 0.08 | 6 per month | 0.00 | (0.07) | 4.58 | (5.23) | 19.71 | |
| AVIR | Atea Pharmaceuticals | 0.02 | 9 per month | 3.04 | 0.09 | 4.64 | (4.43) | 17.79 | |
| ASMB | Assembly Biosciences | 1.29 | 8 per month | 0.00 | (0.05) | 5.85 | (6.65) | 18.53 |
Other Forecasting Options for Enanta Pharmaceuticals
For every potential investor in Enanta, whether a beginner or expert, Enanta Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Enanta Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Enanta. Basic forecasting techniques help filter out the noise by identifying Enanta Pharmaceuticals' price trends.Enanta Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Enanta Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Enanta Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Enanta Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Enanta Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Enanta Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Enanta Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Enanta Pharmaceuticals stock market strength indicators, traders can identify Enanta Pharmaceuticals entry and exit signals to maximize returns.
Enanta Pharmaceuticals Risk Indicators
The analysis of Enanta Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Enanta Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting enanta stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.45 | |||
| Semi Deviation | 2.61 | |||
| Standard Deviation | 3.08 | |||
| Variance | 9.51 | |||
| Downside Variance | 8.16 | |||
| Semi Variance | 6.83 | |||
| Expected Short fall | (2.79) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Enanta Pharmaceuticals
The number of cover stories for Enanta Pharmaceuticals depends on current market conditions and Enanta Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Enanta Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Enanta Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Enanta Pharmaceuticals Short Properties
Enanta Pharmaceuticals' future price predictability will typically decrease when Enanta Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Enanta Pharmaceuticals often depends not only on the future outlook of the potential Enanta Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Enanta Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 21.3 M | |
| Cash And Short Term Investments | 188.9 M |
Check out Historical Fundamental Analysis of Enanta Pharmaceuticals to cross-verify your projections. For information on how to trade Enanta Stock refer to our How to Trade Enanta Stock guide.You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Enanta Pharmaceuticals. Projected growth potential of Enanta fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Enanta Pharmaceuticals assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth (0.66) | Earnings Share (3.84) | Revenue Per Share | Quarterly Revenue Growth 0.035 | Return On Assets |
The market value of Enanta Pharmaceuticals is measured differently than its book value, which is the value of Enanta that is recorded on the company's balance sheet. Investors also form their own opinion of Enanta Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Enanta Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Enanta Pharmaceuticals' market value can be influenced by many factors that don't directly affect Enanta Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Enanta Pharmaceuticals' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Enanta Pharmaceuticals should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Enanta Pharmaceuticals' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.